Middle East and North Africa
Regional Overview
The marginalised and criminalised populations of men who have sex with men and injecting drug users are most affected by HIV in this region. Injecting drug use is fuelling HIV epidemics in Iran and Libya and contributes to those in several other countries in the region. Drug-related offences result in severe penalties in this region, including… Read more
Injecting Drug Use, HIV and Hepatitis C
The following maps and table outline the current available data on injecting drug use, as well as the prevalence of HIV and hepatitis C among injecting populations in the Middle East and North Africa. The map below illustrates HIV prevalence among injecting drug users in countries of the region. The map below illustrates hepatitis C… Read more
Harm Reduction Policies
Few countries in this region have an explicit supportive reference to harm reduction in their national policies on HIV and/or drugs. These are illustrated in the map and table below. Although policy wording is not necessarily indicative of the implementation of effective harm reduction measures in a country, it does indicate governmental… Read more
Harm Reduction Programmes
Key harm reduction interventions (including needle and syringe exchange and opioid substitution therapy) are available in some countries in this region, as illustrated in the maps and table below. Even where services exist, coverage remains insufficient and repressive legal and policy frameworks present a substantial barrier to effective harm… Read more